Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 6, 2000, Pages 906-913

  Montón, Mercedes ^a   Jiménez, Ana ^a   Núñez, Antonio ^a   López Blaya, Almudena ^a   Fairé, Jerónimo ^a   Gómez, Juan ^a   Zalba, Luis Rico ^a   Miguel, Lourdes Sanchez De ^a   Casado, Santos ^a   López Farré, Antonio ^a,b  

^a Cardiovasc Res Hypertension Lab   (Spain)

^b Fund Jiménez Díaz   (Spain)

Author keywords

Angiotensin II; Platelets; Receptors; Thromboxane A2

Indexed keywords

CANDESARTAN; IRBESARTAN; LOSARTAN; TELMISARTAN; THROMBOXANE A2 RECEPTOR; VALSARTAN;

ARTICLE; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADULT; ANGIOTENSIN II; ANTIBODIES, MONOCLONAL; BENZIMIDAZOLES; BENZOATES; BINDING, COMPETITIVE; BIPHENYL COMPOUNDS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMIDAZOLES; LOSARTAN; PLATELET ACTIVATION; PYRIDINES; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TETRAZOLES; THROMBOXANE A2; TIME FACTORS; VALINE;

EID: 12944268370     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200006000-00012     Document Type: Article

References (8)

1. Wong PC, Price WA Jr, Chiu AT, et al. Nonpeptide angiotensin II receptor antagonist: studies with EXP9270 and DuP753. Hypertension 1990;15:823-34.
2. Siegl PKS. Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist. J Hypertens 1993;11:S19-22.
3. Burrell LM, Johnston CI. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease. Drugs Aging 1997;10:421-34.
4. Patrono C, Renda G. Platelet activation and inhibition in unstable coronary syndromes. Am J Candiol 1997;80:17E-20E.
5. 2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. J Pharmacol Exp Ther 1994;268:747-52.
6. 2-induced contractions in canine coronary arteries. J Pharmacol Exp Ther 1997;281:1065-70.
7. Guerra JI, Montón M, Rodríguez-Feo JA, et al. Effect of Iosartan on human platelet activation. J Hypertens 1999;17:447-52.
8. López-Farré A, Caramelo C, Esteban A, et al. Effects of aspirin on platelet-neutrophil interactions: role of nitric oxide and endothelin-1. Circulation 1995;91:2080-8.